| Patents for C12N 1 - Micro-organisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving micro-organisms or compositions thereof; Processes of preparing or isolating a composition containing a micro-organism; Culture media therefor (148,866) |
|---|
| 05/16/2001 | EP1099753A1 Method for growing Burkholderia cepacia in a cobalt-containing medium and use thereof for degradating TBA or TAA |
| 05/16/2001 | EP1098991A1 Novel methods for the identification of ligand and target biomolecules |
| 05/16/2001 | EP1098986A2 A polynucleotide comprising a ubiquitous chromatin opening element (ucoe) |
| 05/16/2001 | EP1098984A2 Chorismate biosynthesis enzymes |
| 05/16/2001 | EP1098980A2 $i(STREPTOCOCCUS SUIS) VACCINES AND DIAGNOSTIC TESTS |
| 05/16/2001 | EP1098978A1 Gbs toxin receptor |
| 05/16/2001 | EP1098976A2 Androgen receptor coactivators |
| 05/16/2001 | EP1098975A1 Orphan cytokine receptor |
| 05/16/2001 | EP1098973A1 Human lcb kinase 1 |
| 05/16/2001 | EP1098972A1 Protein similar to neuroendocrine-specific protein, and encoding cdna |
| 05/16/2001 | EP1098970A1 Human sbpsapl gene with homology to the prosaposin family of neurotrophic factors |
| 05/16/2001 | EP1098969A2 Use of nucleic acid molecules as antiviral agents |
| 05/16/2001 | EP1098963A2 Chorismate synthase from plants |
| 05/16/2001 | EP1098957A1 Transferring materials into cells using porous silicon |
| 05/16/2001 | EP1098956A1 Improved device and method for lysis of micro-organisms |
| 05/16/2001 | EP1098904A1 Axor10, a g-protein coupled receptor |
| 05/16/2001 | EP1084709A9 Oral recombinant lactobacilli vaccines |
| 05/16/2001 | EP0994948B1 Tgf beta rii receptor nucleic sequence, coded peptide, and uses |
| 05/16/2001 | EP0728211B1 Process of producing highly transformable bacterial cells and cells produced thereby |
| 05/16/2001 | EP0628082B1 Agrobacterium strains capable of site-specific recombination |
| 05/16/2001 | CN1295621A Pathogen-inducible promoter |
| 05/16/2001 | CN1295619A Salicylate pathway gene and its use for induction of resistance in plants |
| 05/16/2001 | CN1295616A Tumor-associated antigen derivatives from MAGE family, and nucleic acid sequence encoding them |
| 05/16/2001 | CN1295614A Modulator for function of receptor of TNF/NGF receptor family and other protein |
| 05/16/2001 | CN1295131A Method for production of L-lysine using coryneform bacterial fermentation |
| 05/16/2001 | CN1295127A Plasmid from glutamic acid coryneform and its use |
| 05/16/2001 | CN1295125A Filamentous fungus passing, culturing, coating and preserving method |
| 05/16/2001 | CN1294931A Preparation of composite health article of edible fungi |
| 05/16/2001 | CN1294838A Production technology of specific anti-fouling agent for edible fungus |
| 05/16/2001 | CN1065916C Polypeptides relating biology synthetic cobalamins and/or cobamides, coding DNA sequence of polypeptides, process for preparing them and use |
| 05/16/2001 | CN1065914C Biosynthesized serine and its related product and process |
| 05/16/2001 | CN1065913C Disinfect peptide-X gene structure, prodn tech. and use thereof |
| 05/16/2001 | CN1065911C Method for transferring human solid tumor Endostatin gene bifidobacteria |
| 05/16/2001 | CN1065910C Anti-grain crops disease inoreasing output genetic engineering bacterium fluorescence 93 and preparation method |
| 05/16/2001 | CN1065909C Microorganisms for production of tryptophan and process for preparation thereof |
| 05/16/2001 | CN1065767C Application of bat moth variotin as immunomodulator |
| 05/15/2001 | US6232527 Structure specific endonuclease in dna replication and nucleotide excision repair reactions for gene targeting and production of male sterile plants |
| 05/15/2001 | US6232459 Synaptojanin isoform |
| 05/15/2001 | US6232458 Proteins used in pharmaceutical human and veterinary applications; adapted to provide enhanced expression |
| 05/15/2001 | US6232457 Recombinant vanadium haloperoxidases and their uses |
| 05/15/2001 | US6232454 Nucleic acid and amino acid sequences and use in diagnosis, treatment, and prevention of cancer and immune disorders |
| 05/15/2001 | US6232452 Autosomal dominant disorder of growths in many tissues and organs identified on chromosome 16 deletion mutations; use in disease diagnosis and screening; the gene may behave as a tumor suppressor |
| 05/15/2001 | US6232449 Persephin and related growth factors |
| 05/15/2001 | US6232447 Antibody immunoreactive with a human cytokine designated LERK-6 |
| 05/15/2001 | US6232443 Useful markers in diagnosing and monitoring cancerous renal cells; detecting cell proliferative disorders |
| 05/15/2001 | US6232440 Of given amino acid sequence; screening for agonists and antagonists; use in diagnosis, prevention and treatment of cancer, immune disorders, and neurological disorders |
| 05/15/2001 | US6232292 3-dehydroquinate synthase |
| 05/15/2001 | US6232291 Cytostatin III |
| 05/15/2001 | US6232112 Reagents and methods for diversification of DNA |
| 05/15/2001 | US6232111 Method for improving culture medium for recombinant yeast |
| 05/15/2001 | US6232110 Coding sequence for protein phosphatase methylesterase, recombinant DNA molecules and methods |
| 05/15/2001 | US6232108 Prenylcysteine carboxyl methyltransferase, DNA encoding same, and a method of screening for inhibitors thereof |
| 05/15/2001 | US6232107 Nucleotide sequence coding green fluorescent protein; for use in diagnosis of microorganism infection |
| 05/15/2001 | US6232102 Glucosyltransferase gene gtfe from Amycolatopsis orientalis |
| 05/15/2001 | US6232100 Nucleotide sequence which codes for hormone-regulating neuropeptide; diagnosis and therapy of nervous system disorders; probes; primers |
| 05/15/2001 | US6232097 Nucleotide sequences coding enzymatic polypeptide; prevent bacterial infection; wound healing agents; for vaccine development |
| 05/15/2001 | US6232094 DNA encoding human κ casein and process for obtaining the protein |
| 05/15/2001 | US6232077 Genetic engineering and expression; cancer diagnosis |
| 05/15/2001 | US6232074 Functional gene array in yeast |
| 05/15/2001 | US6232070 Pharmacological targeting of mRNA cap formation |
| 05/15/2001 | US6231871 Live in ovo vaccine |
| 05/15/2001 | US6231870 Oral administration of pneumoccal antigens |
| 05/15/2001 | US6231854 Methioninase formulations and use in diagnostic methods |
| 05/15/2001 | CA2083948C Glyphosate tolerant plants |
| 05/15/2001 | CA2078858C Expression of heterologous protein in yeast |
| 05/15/2001 | CA1341231C Primary biliary cirrhosis autoantigen |
| 05/15/2001 | CA1341230C Amino acid sequence of l-phenylalanine ammonia-lyase, structural gene thereof, novel dna sequence containing same, novel recombinant dna plasmid containing same transformant formed therewith, and process for the production of l-phenylalanine by using same |
| 05/10/2001 | WO2001033221A1 Axor35, a g-protein coupled receptor |
| 05/10/2001 | WO2001033199A2 Universal fluorescent sensors |
| 05/10/2001 | WO2001032936A1 Degradation of polycyclic aromatic hydrocarbons |
| 05/10/2001 | WO2001032927A2 Tissue specific genes of diagnostic import |
| 05/10/2001 | WO2001032926A2 Differentially expressed genes involved in angiogenesis, the polypeptides encoded thereby, and methods of using the same |
| 05/10/2001 | WO2001032910A2 27 human secreted proteins |
| 05/10/2001 | WO2001032905A1 Process for producing a product containing antihypertensive tripeptides |
| 05/10/2001 | WO2001032902A1 Method for degrading polylactate resins |
| 05/10/2001 | WO2001032896A1 Protein expression systems for non-pathogenic <i>kinetoplastidae</i> |
| 05/10/2001 | WO2001032890A1 L-pantolactone-hydrolase and a method for producing d-pantolactone |
| 05/10/2001 | WO2001032889A1 Murine serine/threonine kinase, yak3 |
| 05/10/2001 | WO2001032888A2 Human transferase molecules |
| 05/10/2001 | WO2001032882A2 Nucleic acids and proteins from group b streptococcus |
| 05/10/2001 | WO2001032879A2 Method for producing recombinant interleucin-8 and interleucin-8 muteins |
| 05/10/2001 | WO2001032878A2 A novel polypeptide hormone phosphatonin |
| 05/10/2001 | WO2001032876A2 Compositions and methods for determining interactions of mitochondrial components, and for identifying agents that alter such interactions |
| 05/10/2001 | WO2001032869A1 HUMAN PROTEINS BINDING TO HUMAN TYROSINE KINASE Hck AND GENES ENCODING THE SAME |
| 05/10/2001 | WO2001032867A1 Polypeptides with expanded primary signalling motifs |
| 05/10/2001 | WO2001032866A2 Hybrid adaptor receptors |
| 05/10/2001 | WO2001032865A1 Human gpr27-like g-protein coupled receptor polypeptide and polynucleotide sequences |
| 05/10/2001 | WO2001032864A2 Gpcr-kd5 polypeptides and dna sequences thereof |
| 05/10/2001 | WO2001032837A1 19 human secreted proteins |
| 05/10/2001 | WO2001032836A1 Lactobacillus helvetius producing antihypertensive di- and tripeptides |
| 05/10/2001 | WO2001032835A1 Method of freeze-drying different microorganisms |
| 05/10/2001 | WO2001032831A2 Screening and use of agents which block or activate intein splicing utilizing natural or homologous exteins |
| 05/10/2001 | WO2001032830A2 Process for producing, methods and compositions of glucuronoxylomannan as nutriceutical agent from higher basidiomycetes mushroom |
| 05/10/2001 | WO2001032712A2 Antibody diversity generation |
| 05/10/2001 | WO2001032710A1 Dog and rabbit motilin receptor orthologs |
| 05/10/2001 | WO2001032709A2 Polypeptides with non-natural primary signalling motifs |
| 05/10/2001 | WO2001032704A1 Choline transporter like (ctl) membrane proteins involved in choline transport |
| 05/10/2001 | WO2001032696A2 Traf family proteins |
| 05/10/2001 | WO2001032687A1 10 human secreted proteins |
| 05/10/2001 | WO2001032685A2 Gene expression directed by a super-psa promoter |